Rompharm Company S.R.L., established in 1994, is a prominent pharmaceutical manufacturer based in Romania. With a mission to provide high-quality medicines at affordable prices, the company operates one of the most modern pharmaceutical plants in the country, adhering to European Union Good Manufacturing Practice (EU-GMP) standards. Rompharm specializes in the development, production, and commercialization of a diverse portfolio including sterile solutions (ophthalmic and injectable), solid oral dosage forms, and other pharmaceutical products. The company has a significant international footprint, exporting its products to over 25 countries across Europe, the CIS region, Asia, and Africa.
Serves as the central hub for corporate management, strategic planning, research and development, manufacturing operations, quality assurance, and global export coordination for Rompharm's pharmaceutical products.
The Otopeni campus features state-of-the-art, EU-GMP certified manufacturing facilities for sterile products (including ophthalmic drops, sprays, and injectable solutions), solid dosage forms, and advanced research and development laboratories equipped for pharmaceutical innovation.
The work culture at Rompharm Company is characterized by a strong emphasis on scientific excellence, strict adherence to quality and regulatory standards (GMP), continuous improvement, and innovation in pharmaceutical development. Employees often work in a collaborative environment focused on producing affordable and effective medicines for patients.
The Otopeni headquarters and integrated facility are crucial to Rompharm's identity and success. It allows for end-to-end control over the pharmaceutical lifecycle, from R&D to manufacturing and distribution, ensuring high-quality standards and enabling its extensive export operations to international markets.
Rompharm Company has established a significant global presence, primarily through the export of its pharmaceutical products. The company's medicines, including specialized ophthalmic preparations, injectable solutions, and various solid dosage forms, are distributed to over 25 countries. Key export regions include other European nations, countries in the Commonwealth of Independent States (CIS), Asia, and Africa. This global reach is supported by its EU-GMP certified manufacturing facilities in Romania and a dedicated export and regulatory affairs team that ensures product compliance with diverse international market standards.
Str. Eroilor nr. 1A
Otopeni
Ilfov
Romania
Address: Str. Eroilor nr. 1A, Otopeni, 075100, Ilfov, Romania
This facility serves as the core production, innovation, and distribution hub for Romania and is the primary center for managing exports to over 25 countries across Europe, the CIS region, Asia, and Africa. All major company functions are centralized here.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Rompharm Company' leadership includes:
Rompharm Company has been backed by several prominent investors over the years, including:
Based on publicly available information and news reports, there have been no major C-level executive hires or departures announced at Rompharm Company in the last 12 months. The company's leadership team appears to be stable.
Discover the tools Rompharm Company uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Rompharm Company likely uses standard corporate email formats, typically combining employee names with their domain '@rompharm.ro'. Common patterns include first initial followed by last name, or first name separated from last name by a dot.
[first_initial][last]@rompharm.ro or [first].[last]@rompharm.ro
Format
dvasile@rompharm.ro
Example
75%
Success rate
Bursa.ro • November 21, 2023
Rompharm Company has invested 25 million euros in a new production facility in Otopeni, dedicated to oncological drugs. This expansion aims to increase production capacity and introduce new product lines, reinforcing its commitment to the Romanian and international markets....more
Ziarul Financiar (zf.ro) • November 20, 2023
Pharmaceutical manufacturer Rompharm Company, based in Otopeni, reported a turnover of 534 million lei (approximately 108 million euros) in 2022, marking a 10% increase from the previous year. The company employs over 850 people and continues to invest in expanding its production capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Rompharm Company, are just a search away.